11C-choline PET/CT in the diagnosis of prostate cancer - Abstract

11C-choline has been used in the diagnosis and follow-up of patients with prostate cancer for years.

Choline PET/CT has been available in human care since March, 2014 in our country. Unfortunately this examination has not been reimbursed by the National Health Insurance so far. We retrospectively analysed and assessed the results of 40 patients who underwent 11C-choline PET/CT on the basis of previous literature. As our study group was heterogeneous statistical analysis was not performed.

Written by:
Garai I, Farkas B, Oszlánszki A, Berczi C, Flaskó T, Galuska L.   Are you the author?
ScanoMed Nukleáris Medicina Oktató és Kutató Kft., Debrecen, Hungary; Nukleáris Medicina Intézet, Debreceni Egyetem, Debrecen, Hungary; Urológiai Klinika, Debreceni Egyetem, Debrecen, Hungary.  

Reference: Magy Onkol. 2015 Mar;59(1):25-9.

 
PubMed Abstract
PMID: 25763910

Article in Hungarian.

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe